PARVEN ALVIN S
Insider CIK 1231950 · ALXN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-06-15 | 2017-06-16 | 835 | $116.78 | $97.5K | 7,568 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-05-10 | 2017-05-12 | 2,030 | — | $0 | 8,403 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2017-01-05 | 2017-01-09 | 3,237 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2017-01-05 | 2017-01-09 | 3,425 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2017-01-05 | 2017-01-09 | 5,572 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2017-01-05 | 2017-01-09 | 7,932 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 599 | $137.56 | $82.4K | 4,875 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 853 | $133.65 | $114.0K | 5,520 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 278 | $141.23 | $39.3K | 6,373 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 1,433 | $140.59 | $201.5K | 6,651 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 5,350 | $139.49 | $746.3K | 8,084 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 5,176 | $138.60 | $717.4K | 13,434 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 7,375 | $137.56 | $1.01M | 18,610 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 369 | $135.70 | $50.1K | 25,985 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 185 | $133.95 | $24.8K | 26,354 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2017-01-05 | 2017-01-09 | 3,425 | $96.35 | $330.0K | 26,539 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2017-01-05 | 2017-01-09 | 3,237 | $85.75 | $277.6K | 23,114 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2017-01-05 | 2017-01-09 | 5,572 | $49.43 | $275.4K | 19,877 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2017-01-05 | 2017-01-09 | 7,932 | $26.64 | $211.3K | 14,305 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 22 | $141.22 | $3.1K | 3,880 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 117 | $140.59 | $16.4K | 3,902 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 435 | $139.49 | $60.7K | 4,019 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 421 | $138.60 | $58.4K | 4,454 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 15 | $133.95 | $2.0K | 5,505 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-01-05 | 2017-01-09 | 31 | $135.69 | $4.2K | 5,474 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2016-08-22 | 2016-08-24 | 15,000 | $18.01 | $270.1K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-08-22 | 2016-08-24 | 15,000 | $136.53 | $2.05M | 6,373 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2016-08-22 | 2016-08-24 | 15,000 | $18.01 | $270.1K | 21,373 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-08-15 | 2016-08-24 | 700 | $135.51 | $94.9K | 6,373 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2016-05-13 | 2016-05-13 | 2,294 | $138.86 | $318.5K | 2,294 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-05-13 | 2016-05-13 | 835 | — | $0 | 7,073 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-11-02 | 2015-11-04 | 895 | $178.73 | $160.0K | 4,645 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-05-06 | 2015-05-08 | 2,343 | $155.01 | $363.2K | 2,343 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-05-06 | 2015-05-08 | 700 | — | $0 | 5,540 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-11-11 | 2014-11-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-11 | 2014-11-13 | 15,000 | $195.66 | $2.93M | 4,840 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-11-11 | 2014-11-13 | 15,000 | $18.01 | $270.1K | 19,840 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-05-13 | 2014-05-15 | 12,276 | $16.83 | $206.6K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-05-13 | 2014-05-15 | 12,276 | $16.83 | $206.6K | 17,116 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-05-13 | 2014-05-15 | 12,276 | $160.78 | $1.97M | 4,840 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2014-05-05 | 2014-05-07 | 2,785 | $159.70 | $444.8K | 2,785 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-28 | 2014-03-04 | 895 | — | $0 | 5,735 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-11 | 2014-02-13 | 2,471 | $174.06 | $430.1K | 4,840 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2013-05-07 | 2013-05-09 | 3,425 | — | $0 | 3,425 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-12 | 3,115 | $92.00 | $286.6K | 7,311 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2013-02-06 | 2013-02-08 | 2,471 | — | $0 | 11,195 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-11-19 | 2012-11-21 | 30,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-11-19 | 2012-11-21 | 9,306 | $90.74 | $844.4K | 28,005 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-11-19 | 2012-11-21 | 19,281 | $91.51 | $1.76M | 8,724 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-11-19 | 2012-11-21 | 1,413 | $92.16 | $130.2K | 7,311 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-11-19 | 2012-11-21 | 30,000 | $10.84 | $325.2K | 37,311 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-06-08 | 2012-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-06-08 | 2012-06-08 | 30,000 | $91.01 | $2.73M | 7,311 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-06-08 | 2012-06-08 | 30,000 | $8.18 | $245.4K | 37,311 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2012-05-08 | 2012-05-09 | 3,237 | — | $0 | 3,237 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | P Buy | 2012-03-05 | 2013-12-11 | 140 | $84.95 | $11.9K | 7,451 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-21 | 2012-02-23 | 5,450 | $81.51 | $444.2K | 7,311 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-03 | 2012-02-06 | 3,115 | — | $0 | 12,761 | SEC↗ |